1.
Bioorg Med Chem Lett
; 15(1): 171-5, 2005 Jan 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15582434
RESUMEN
We report the discovery and optimization of substituted 2-piperazinecarboxamides as potent and selective agonists of the melanocortin subtype-4 receptor. Further in vivo development of lead agonist, MB243, is disclosed.